Case Reports
doi: 10.1016/s0140-6736(78)90196-4.
Antithrombin-III transfusion in disseminated intravascular coagulation
- PMID: 76800
- DOI: 10.1016/s0140-6736(78)90196-4
Item in Clipboard
Case Reports
Antithrombin-III transfusion in disseminated intravascular coagulation
Lancet.
.
Abstract
Three patients with a severe bleeding disorder and disseminated intravascular coagulation were effectively treated with human antithrombin-III concentrates. This treatment, followed by administration of prothrombin complex and platelet suspensions, resulted in a normal haemostasis, which was maintained during clinical investigations and surgery.
Similar articles
-
Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.Br J Haematol. 2009 Apr;145(1):24-33. doi: 10.1111/j.1365-2141.2009.07600.x. Epub 2009 Feb 12. Br J Haematol. 2009. PMID: 19222477
-
[Severe pregnancy hemostasis disorders: diagnosis and therapeutic procedures].Geburtshilfe Frauenheilkd. 1982 Dec;42(12):853-6. doi: 10.1055/s-2008-1037171. Geburtshilfe Frauenheilkd. 1982. PMID: 6984403 German.
-
[Disseminated intravascular coagulation disorder in the 2d trimester of pregnancy. Case report from the 16th week of pregnancy with spontaneous parturition at term].Geburtshilfe Frauenheilkd. 1989 Jul;49(7):679-81. doi: 10.1055/s-2008-1026678. Geburtshilfe Frauenheilkd. 1989. PMID: 2777055 German.
-
Indications for prothrombin complex concentrates in massive transfusions.Thromb Res. 1999 Aug 15;95(4 Suppl 1):S63-9. doi: 10.1016/s0049-3848(99)00086-9. Thromb Res. 1999. PMID: 10499911 Review.
-
[Therapy of disseminated intravascular coagulation].Rinsho Byori. 1985 Jun;Spec No 63:79-89. Rinsho Byori. 1985. PMID: 3930817 Review. Japanese. No abstract available.
Cited by
-
Use of antithrombin III in critical patients.Intensive Care Med. 1994 Nov;20(8):577-80. doi: 10.1007/BF01705725. Intensive Care Med. 1994. PMID: 7706571 Clinical Trial.
-
Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis.Intensive Care Med. 1998 Jul;24(7):663-72. doi: 10.1007/s001340050642. Intensive Care Med. 1998. PMID: 9722035 Clinical Trial.
-
Criteria for evaluating evidence that laboratory abnormalities are associated with the development of venous thromboembolism.CMAJ. 2000 Oct 17;163(8):1016-21. CMAJ. 2000. PMID: 11068575 Free PMC article. Review.
-
Low antithrombin III in neonatal shock: DIC or non-specific protein depletion?Eur J Pediatr. 1986 Dec;145(6):500-3. doi: 10.1007/BF02429051. Eur J Pediatr. 1986. PMID: 3816852
-
Proteolytic activity and fatal gram-negative sepsis in burned mice: effect of exogenous proteinase inhibition.Infect Immun. 1994 Jun;62(6):2158-64. doi: 10.1128/iai.62.6.2158-2164.1994. Infect Immun. 1994. PMID: 8188336 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
